Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:21 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 217–240 of 369 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mass Clear all

Conditions: Low Bone Mass, Osteoporosis, Postmenopausal
Interventions: DHEA, Placebo, Exercise; Other · Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 55 Years to 85 Years · Female only
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Osteoporosis
Interventions: Treadmill Exercise, Magnitude of Ca loss during Exercise at 26 degrees Celcius; Procedure
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 60 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Complex Aortic Aneurysms, Thoracoabdominal Aneurysms, Pararenal Aneurysms, Juxtarenal Aneurysms, Marfan Syndrome, Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Aortic Arch Aneurysm
Interventions: Custom Made Fenestrated or Branched Stent Graft; Device
Lead sponsor: Andres Schanzer; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Diabetes, Myocardial Infarction, Stroke, Kidney Diseases, Bone Diseases, Dyslipidemia
Interventions: Lifestyle Intervention, Diabetes Support and Education; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 55 Years to 76 Years
Enrollment: 5,145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2020
U.S. locations: 18
States / cities: Birmingham, Alabama • Phoenix, Arizona • Los Angeles, California + 14 more

Conditions: Primary Hyperparathyroidism, Hypercalcemia, Vitamin D Deficiency, Osteoporosis, Osteopenia
Interventions: Placebo, Vitamin D3; Dietary Supplement
Lead sponsor: Columbia University; Other
Eligibility: 45 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoporosis (Senile)
Interventions: doxercalciferol capsules, Hectorol®, Matched Placebo (Capsules); Drug
Lead sponsor: Creighton University; Other
Eligibility: 60 Years to 78 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1989 – 1994
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Vitamin D Status, Glucose Tolerance, Blood Pressure, Bone Mineral Density, Hyperlipidemia
Interventions: Vitamin D; Other
Lead sponsor: Baltimore VA Medical Center; Federal
Eligibility: 45 Years to 85 Years
Enrollment: 362 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteoporosis, Osteopenia
Interventions: Calcium carbonate, Calcium Phosphate; Drug
Lead sponsor: Creighton University; Other
Eligibility: 60 Years to 85 Years · Female only
Enrollment: 241 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteoporosis
Interventions: BONISTEIN(R) bone blend, Placebo; Dietary Supplement
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Sarcopenic Obesity
Interventions: THERABand resistance exercise bands; Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 50 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bone Mineral Density
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 10 Years to 12 Years · Female only
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Physical Activity, Nutrition
Interventions: Physical activity, Calcium supplement; Procedure · Drug
Lead sponsor: South Dakota State University; Other
Eligibility: 3 Years to 4 Years
Enrollment: 224 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2003
U.S. locations: 1
States / cities: Brookings, South Dakota

Conditions: Postmenopausal Osteoporosis
Interventions: AGA2118, Placebo; Drug · Other
Lead sponsor: Angitia Biopharmaceuticals; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 5
States / cities: Birmingham, Alabama • Gainesville, Georgia • Albuquerque, New Mexico + 2 more

Conditions: Hemophilia A, Hemophilia B, Vitamin D Deficiency
Interventions: Vitamin D and calcium; Dietary Supplement
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 2 Years to 21 Years · Male only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Autism Spectrum Disorder, Bone Health
Interventions: 1. Intranasal oxytocin spray, 2. Intranasal placebo spray, 3. Intranasal Oxytocin spray; Drug
Lead sponsor: Elizabeth Austen Lawson; Other
Eligibility: 6 Years to 18 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: Boston, Massachusetts • Charlottesville, Virginia

Conditions: Spinal Cord Injury
Interventions: Vibration Therapy; Procedure
Lead sponsor: Logan College of Chiropractic; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 2
States / cities: Chesterfield, Missouri

Conditions: Risperidone-induced Hyperprolactinemia
Interventions: Calcium and Vitamin D, Placebo; Drug · Other
Lead sponsor: Chadi A. Calarge; Other
Eligibility: 5 Years to 17 Years · Male only
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Menopause
Interventions: Probiotic, Placebo; Dietary Supplement · Other
Lead sponsor: Lallemand Health Solutions; Industry
Eligibility: 40 Years to 59 Years · Female only
Enrollment: 144 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 5
States / cities: Lake Worth, Florida • Port Saint Lucie, Florida • Atlanta, Georgia + 2 more

Conditions: Osteoporosis, Postmenopausal
Interventions: Arzoxifene, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 60 Years to 85 Years · Female only
Enrollment: 9,369 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Elk Grove, Illinois

Conditions: Hypopituitarism
Interventions: Arimidex (Anastrozole), Placebo, Growth Hormone; Drug
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 11 Years to 18 Years · Male only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2010
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Osteoporosis
Interventions: Not listed
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 7 Years to 40 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Healthy, Involutional Depression, Osteoporosis
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years and older
Enrollment: 585 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1994 – 2007
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Werner Syndrome
Interventions: Progerinin; Drug
Lead sponsor: PRG Science & Technology Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Osteoporosis
Interventions: Vitamin D; Drug
Lead sponsor: National Center for Research Resources (NCRR); NIH
Eligibility: 25 Years to 75 Years · Female only
Healthy volunteers: Accepts healthy volunteers
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women

PTH And Calcium Responses to Exercise (PACE) in Older Adults

Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices

Look AHEAD: Action for Health in Diabetes

Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D

To Study the Efficacy and Safety of Doxercalciferol on Spinal and Femoral Density in Postmenopausal Osteopenic Women in a Long Term 2 Year Study

Vitamin D Retrospective Study and Role With Disease

Adding Phosphorus to Osteoporosis Drug Treatment

Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health

Feasibility of At-Home Chair-Based Resistance Band Training to Improve Balance, Strength, and Bone Density in Older Adults

The Role of Impact Activity in Peripubertal Bone Accrual

Physical Activity, Calcium, and Bone in Children

A Trial Evaluating Efficacy of AGA2118 in PostMenopausal Women wIth Low Bone MasS (ARTEMIS)

Correlation Between Vitamin D Status and Bone Mineral Density in Patients With Hemophilia

Oxytocin Effects on Bone in Children With Autism Spectrum Disorder

The Effect of Vibration Therapy on the Bone Density of the Tiba in Patients With Spinal Cord Injury

Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia

The Effects of a Novel Probiotic Supplement on Menopausal Symptoms and Bone Health

Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer

Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys

Longitudinal Study of Bone Mineral Density in Survivors of Solid Pediatric Cancers

Bone Mineral Density in Women With Major Depression

Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

The Relationship Between Vitamin D, Fingernail Thickness and Bone Density